Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Single cell polarity in liquid phase facilitates tumour metastasis.

Lorentzen A, Becker PF, Kosla J, Saini M, Weidele K, Ronchi P, Klein C, Wolf MJ, Geist F, Seubert B, Ringelhan M, Mihic-Probst D, Esser K, Roblek M, Kuehne F, Bianco G, O'Connor T, Müller Q, Schuck K, Lange S, Hartmann D, Spaich S, Groß O, Utikal J, Haferkamp S, Sprick MR, Damle-Vartak A, Hapfelmeier A, Hüser N, Protzer U, Trumpp A, Saur D, Vartak N, Klein CA, Polzer B, Borsig L, Heikenwalder M.

Nat Commun. 2018 Feb 28;9(1):887. doi: 10.1038/s41467-018-03139-6.

2.

Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations.

Jabs J, Zickgraf FM, Park J, Wagner S, Jiang X, Jechow K, Kleinheinz K, Toprak UH, Schneider MA, Meister M, Spaich S, Sütterlin M, Schlesner M, Trumpp A, Sprick M, Eils R, Conrad C.

Mol Syst Biol. 2017 Nov 27;13(11):955. doi: 10.15252/msb.20177697.

3.

Novel biomarkers for risk stratification in pulmonary arterial hypertension.

Zelniker T, Uhlmann L, Spaich S, Friedrich J, Preusch MR, Meyer FJ, Katus HA, Giannitsis E.

ERJ Open Res. 2015 Oct 19;1(2). pii: 00008-2015. eCollection 2015 Oct.

4.

Fibroblast growth factor 23 (FGF-23) is an early predictor of mortality in patients with cardiac arrest.

Spaich S, Zelniker T, Endres P, Stiepak J, Uhlmann L, Bekeredjian R, Chorianopoulos E, Giannitsis E, Backs J, Katus HA, Preusch MR.

Resuscitation. 2016 Jan;98:91-6. doi: 10.1016/j.resuscitation.2015.11.012. Epub 2015 Nov 30.

PMID:
26655587
5.

The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features.

Aloia A, Petrova E, Tomiuk S, Bissels U, Déas O, Saini M, Zickgraf FM, Wagner S, Spaich S, Sütterlin M, Schneeweiss A, Reitberger M, Rüberg S, Gerstmayer B, Agorku D, Knöbel S, Terranegra A, Falleni M, Soldati L, Sprick MR, Trumpp A, Judde JG, Bosio A, Cairo S, Hardt O.

Breast Cancer Res. 2015 Nov 25;17(1):146. doi: 10.1186/s13058-015-0652-6.

6.

Ongoing controversies surrounding cardiac remodeling: is it black and white-or rather fifty shades of gray?

Spaich S, Katus HA, Backs J.

Front Physiol. 2015 Jul 22;6:202. doi: 10.3389/fphys.2015.00202. eCollection 2015. Review.

7.

Mode of delivery and its influence on women's satisfaction with childbirth.

Spaich S, Welzel G, Berlit S, Temerinac D, Tuschy B, Sütterlin M, Kehl S.

Eur J Obstet Gynecol Reprod Biol. 2013 Oct;170(2):401-6. doi: 10.1016/j.ejogrb.2013.07.040. Epub 2013 Aug 7.

PMID:
23962715
8.

Women's acceptance of a double-balloon device as an additional method for inducing labour.

Kehl S, Welzel G, Ehard A, Berlit S, Spaich S, Siemer J, Sütterlin M.

Eur J Obstet Gynecol Reprod Biol. 2013 May;168(1):30-5. doi: 10.1016/j.ejogrb.2012.12.018. Epub 2013 Jan 6.

PMID:
23298898
9.

F-box and leucine-rich repeat protein 22 is a cardiac-enriched F-box protein that regulates sarcomeric protein turnover and is essential for maintenance of contractile function in vivo.

Spaich S, Will RD, Just S, Spaich S, Kuhn C, Frank D, Berger IM, Wiemann S, Korn B, Koegl M, Backs J, Katus HA, Rottbauer W, Frey N.

Circ Res. 2012 Dec 7;111(12):1504-16. doi: 10.1161/CIRCRESAHA.112.271007. Epub 2012 Sep 12.

10.

Myasthenia gravis in pregnancy: a case report.

Berlit S, Tuschy B, Spaich S, Sütterlin M, Schaffelder R.

Case Rep Obstet Gynecol. 2012;2012:736024. doi: 10.1155/2012/736024. Epub 2012 Jan 26.

11.

Combination of misoprostol and mechanical dilation for induction of labour: a randomized controlled trial.

Kehl S, Ehard A, Berlit S, Spaich S, Sütterlin M, Siemer J.

Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):315-9. doi: 10.1016/j.ejogrb.2011.09.010. Epub 2011 Oct 2.

PMID:
21962943
12.

What are the limits of accuracy in fetal weight estimation with conventional biometry in two-dimensional ultrasound? A novel postpartum study.

Kehl S, Schmidt U, Spaich S, Schild RL, Sütterlin M, Siemer J.

Ultrasound Obstet Gynecol. 2012 May;39(5):543-8. doi: 10.1002/uog.10094.

13.

Affixin (β-parvin) promotes cardioprotective signaling via STAT3 activation.

Luedde M, Spaich S, Hippe HJ, Busch S, Will R, Abu-Taha I, Klein T, Kuhn C, Frank D, Katus HA, Frey N.

J Mol Cell Cardiol. 2011 May;50(5):919-23. doi: 10.1016/j.yjmcc.2011.01.020. Epub 2011 Feb 3.

PMID:
21295579

Supplemental Content

Loading ...
Support Center